Valuation: Senzime AB

Market Cap 62Cr 6.35Cr 5.58Cr 5.19Cr 4.77Cr 8.95Cr 614.75Cr 9.11Cr 24Cr 299.85Cr 24Cr 23Cr 1.04TCr P/E 2026 *
-
P/E 2027 * -
Enterprise Value 62Cr 6.35Cr 5.58Cr 5.19Cr 4.77Cr 8.95Cr 614.75Cr 9.11Cr 24Cr 299.85Cr 24Cr 23Cr 1.04TCr EV / Sales 2026 *
4.86x
EV / Sales 2027 * 3.04x
Free-Float
40.74%
Yield 2026 *
-
Yield 2027 * -
1 day-6.21%
1 week-5.85%
Current month-14.55%
1 month-13.95%
3 months-23.47%
6 months-30.19%
Current year-31.48%
1 week 3.62
Extreme 3.625
4.02
1 month 3.62
Extreme 3.625
4.44
Current year 3.62
Extreme 3.625
6
1 year 3.62
Extreme 3.625
7.38
3 years 3.6
Extreme 3.6
9.6
5 years 2.6
Extreme 2.605
24.9
10 years 2.6
Extreme 2.605
28.5
Manager TitleAgeSince
Chief Executive Officer 53 03/05/2023
Director of Finance/CFO 56 01/01/2022
Chief Tech/Sci/R&D Officer 50 01/01/2023
Director TitleAgeSince
Chairman 53 03/05/2023
Director/Board Member 70 01/01/2016
Director/Board Member 63 05/03/2020
Date Insider Type Main position Quantity % Market Cap.
09/12/25 Buy

Director

15,000 0.0095%
09/12/25 Sell

Director

15,000 0.0095%
28/11/25 Sell

Director

15,900 0.0101%
Change 5-day change 1-year change 3-year change Capi.($)
-6.21%-5.85%-45.75%-27.31% 6.4Cr
-0.36%+1.47%-20.31%-12.51% 18TCr
-0.16%-2.02%-11.02%-7.76% 10TCr
+0.72%-1.53%+3.35%+58.41% 5.85TCr
-0.82%-1.93%+38.23%+58.17% 5.14TCr
-0.33%-4.45%-16.31%-45.42% 4.22TCr
+0.90%-9.29% - - 3.14TCr
-1.57%-9.48%-18.33%-44.73% 2.76TCr
+0.96%0.00%+59.45%-3.62% 2.53TCr
-0.35%-4.87%-6.70%-9.39% 2.05TCr
Average -0.73%+0.13%-1.93%-3.80% 5.37TCr
Weighted average by Cap. -0.18%+3.97%-4.71%-0.07%

Financials

2026 *2027 *
Net sales 13Cr 1.31Cr 1.15Cr 1.07Cr 98.22L 1.84Cr 126.57Cr 1.87Cr 4.98Cr 62Cr 4.91Cr 4.8Cr 214.19Cr 20Cr 2.09Cr 1.84Cr 1.71Cr 1.57Cr 2.94Cr 202.2Cr 3Cr 7.96Cr 99Cr 7.84Cr 7.67Cr 342.16Cr
Net income -6.89Cr -70.52L -62.02L -57.62L -52.99L -99.38L -68Cr -1.01Cr -2.69Cr -33Cr -2.65Cr -2.59Cr -115.56Cr -3.68Cr -37.67L -33.13L -30.77L -28.3L -53.08L -36Cr -54.03L -1.44Cr -18Cr -1.41Cr -1.38Cr -62Cr
Net Debt - -
Logo Senzime AB
Senzime AB (publ.) is a Sweden-based company engaged in the development, manufacture and marketing of biosensors for measuring metabolites in biological fluids, such as human blood and cell culture substrates for the pharmaceutical and healthcare segments. The Company focuses on the following application areas: medical diagnostic instruments, pharmaceutical industry, chemical processing, and food and beverage processing. As of December 31, 2011, the Company marketed three products, namely SENZ-100G, for continuous analysis of glucose in the fermentation solutions; SENZ-100L, for continuous analysis of lactate in fermentation solutions, and SENZ-200G, for continuous analysis of glucose in blood during intensive care.
Employees
59
Date Price Change Volume
23/26/23 SEK 3.700 -6.21% 3,12,087
22/26/22 SEK 3.945 +1.15% 88,367
21/26/21 SEK 3.900 +0.52% 1,68,653
20/26/20 SEK 3.880 +1.57% 2,65,208
17/26/17 SEK 3.820 -2.80% 1,93,517

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. SEZI Stock